Stocks To Buy Now Blog

All posts by Christopher

The 2025 MoneyShow Orlando: Educating Successful Investors and Traders

MoneyShow, a company with a 44-year history of creating successful investors and traders through timely education from leading experts, is proud to announce the 2025 MoneyShow Orlando. This three-day event will offer attendees the chance to learn how to navigate the markets and position themselves for success in the coming year. With a stellar line-up of speakers and panelists, attendees will get to explore cutting-edge ideas in stocks, ETFs, fixed income, options, sectors like energy and technology, and alternative investments.

This Oct. 16-18 event will feature panel discussions, workshops, and keynote addresses from proven industry players and experts. They include Raymond Rondeau, investment strategist and senior technical analyst at The American Association of Individual Investors (“AAII”); Heather Zumarraga, senior vice president of Apex Group; Charles Payne, host of Fox Business’ Making Money with Charles Payne; Alicia Levine, head of investment strategy and equities at BNY Wealth; and Keith Fitz-Gerald, principal at Fitz-Gerald Group.

Some of the topics covered during the three-day conference include:

  • Technical indicators every stock trader needs
  • An investor’s guide to Bitcoin and the next generation of crypto assets
  • The best growth stocks and ETFs to own in the new economy
  • Evidence-backed strategies for today’s markets 

The schedule is set to run from approximately 7:00 am to 7:00 pm Eastern on the first two days, and close at 3:15 pm on the final day.

Just like previous MoneyShow conferences, the Orlando event will offer value to every attendee. They will enjoy four main benefits: getting to learn about new stocks, new funds, and new picks for the year; having access to top money experts both live and in person; growing their business and personal networks; and discovering new products, services, tools, and opportunities. 

Previous attendees of MoneyShow events have praised them for their in-depth MoneyMasters Courses, frequent access to speakers, and the opportunity to explore various investment themes and ideas that have helped them transform their portfolios.

Slots are still open, with discount offers currently running until Oct. 1. This is your chance to learn from and interact with leading economists, analysts, and trading experts in a setting unlike any other. Whether your goal is portfolio growth, risk management, or income generation, take advantage of this chance to prepare for profit opportunities in 2026 and beyond.

To learn more, please visit https://ibn.fm/2hOoC

DGE Presents:  The Medical Affairs AI Immersion Lab

Dynamic Global Events (“DGE”), a life science leader in providing B2B conferences that engage audiences, facilitate information exchange, encourage collaboration, and accelerate partnerships, is proud to announce the Medical Affairs AI Immersion Lab event, scheduled for October 16-17. This unique event, focusing on hands-on working groups developing and editing AI work product in real-time, will empower participants to build a business case for AI among their teams and management.

The Medical Affairs AI Immersion Lab takes into account that AI is not “the coming thing” for pharma, but rather is already here and shaping the future; those who choose to actively adopt and leverage it stand to benefit the most out of what it has to offer. Guided by expert facilitators in a non-judgmental atmosphere, this event provides an opportunity to compare and contrast key platforms.

Over 20 industry experts are scheduled to speak at the event. Some of them include Anjali Mishra, a senior director, medical analytics and intelligence at Daiichi Sankyo; Todd Bresier, an associate director, IBD patient access and digital operations at Takeda; Vivek Mukhatyar, the generative AI medical engagement lead at Pfizer; and Chimene Richa, a medical education outcomes lead at AstraZeneca.

These speakers will discuss and offer their insights on various topics, such as the basics of prompt engineering, applications of large language models (“LLMs”) in medical affairs, deploying machine learning within CRMs to quantify team impact, and distinguishing simple, intermediate, and advanced applications. 

The Medical Affairs AI Immersion Lab is an event unlike any other in the pharma industry. While many choose to dismiss or remain skeptical about AI in this space, this event looks to offer clarity and a chance for people to stay ahead of the curve and leverage fast-evolving AI tools to shape the work that they do. For those curious about AI in pharma, those looking to integrate it into their work, or even those already using AI in their workflow, this event is for you.

To learn more, please visit https://ibn.fm/yrXBp

Beeline Holdings, Inc. (NASDAQ: BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026

  • The company has eliminated more than $7 million in debt, excluding warehouse credit lines tied to loan originations.
  • Q2 2025 revenue rose 27% quarter-over-quarter to $1.7 million, while operating costs fell 40%.
  • Management expects to achieve cash flow positive operations by the first quarter of 2026.
  • Executives to present growth plans at the Centurion One Capital Summit in October 2025.

Beeline Holdings (NASDAQ: BLNE),  a digital mortgage platform redefining the path to homeownership, announced it has paid off over $7 million in debt and is positioning itself to become cash flow positive by the first quarter of 2026. The company said that all secured credit facilities, including senior debentures, were fully repaid as of September 3, 2025. Only short-term warehouse credit lines, which recycle when loans are sold, remain in place (https://ibn.fm/ldSV4).

Chief Executive Nick Liuzza described the milestone as a key strategic goal met ahead of schedule. “Achieving this milestone earlier than planned strengthens our financial foundation and allows us to focus fully on growth and innovation. It’s a testament to our team’s discipline and execution,” he said.

The debt repayment comes as Beeline continues to report stronger financial performance. According to company filings, Q2 2025 revenue reached $1.7 million, a 27% increase from the previous quarter, while operating costs dropped 40% to $5.6 million. The company’s net loss narrowed to $4.1 million, a 68% improvement from Q1, while adjusted EBITDA improved from -$3.5 million to -$2.8 million.

The firm also reported funding $52 million in mortgage loans during the quarter, a 31% rise over Q1. July revenues were 15% higher than April, which had previously been the company’s strongest month in three years. Reduced marketing expenses, down 20% quarter-over-quarter, also contributed to the improved financial position.

Beeline has been expanding its offerings beyond its core mortgage platform. New initiatives include BeelineEQUITY, a program that allows homeowners to sell up to 49% of their equity to investors instead of taking on additional debt. The company completed its first transaction in June and expects to close ten more by late October ahead of a full rollout.

It has also introduced BlinkQC, an AI-powered quality control tool for pre-closing audits, and “Bob,” an AI chatbot designed to assist mortgage applicants. In testing, Bob converted inquiries into leads at six times the rate of human agents, generating $162,500 in revenue at a minimal cost.

Beeline executives will present their growth strategy at the Centurion One Capital 3rd Annual Bahamas Summit on October 28-29, 2025, at the Rosewood Baha Mar Hotel (https://ibn.fm/C5Yrx). The two-day invitation-only event will bring together the world’s leading small cap growth companies to an audience of global growth investors. During the summit, CEO Nick Liuzza, COO Jess Kennedy, and CFO Christopher Moe will meet with investors and participate in panel discussions about the company’s recent achievements and plans for the future.

Liuzza said the company is eager to share its execution track record with investors. “We are well-positioned for explosive growth in 2026 and look forward to sharing our story and going deeper on our unique model,” he said. “Our story is compelling, but what excites us most is how consistently we’ve executed against our vision. We look forward to sharing this with investors – and we think they’ll love what they hear.”

For more information, visit the company’s website at www.makeabeeline.com.

NOTE TO INVESTORS: The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Pursues Growth with Santa Fe and Satellites, Offers Upside in Gold Exploration and Development

This article has been disseminated on behalf of Lahontan Gold and may include a paid advertisement.

  • Lahontan Gold is focused on unlocking value within projects that have historic production, existing infrastructure and jurisdictional support
  • The company’s flagship project is Santa Fe, where it now pursues resource expansion, metallurgical optimization and permitting work
  • Investors drawn to gold in 2025 will notice that juniors such as Lahontan offer a leveraged way to ride the metal’s upside

Gold’s resurgence in 2025 has captured investor attention, and Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is staking its claim in that momentum. This Canada-based exploration company holds four high-potential gold and silver properties in Nevada’s Walker Lane, including the flagship Santa Fe Mine, and is actively advancing work on expansion, permitting and drilling. Drawing from past production and current upside potential, Lahontan is aiming to transform its Walker Lane footprint into a developer with meaningful scale.

Lahontan Gold is focused on unlocking value in oxide gold and silver systems within projects that have historic production, existing infrastructure and jurisdictional support (ibn.fm/idTV3). The company’s flagship project is Santa Fe, a past-producing, open-pit gold and silver mine where it now pursues resource expansion, metallurgical optimization and permitting work (ibn.fm/dBVlD). Additional assets, including West Santa Fe, Moho and Redlich, provide exploration upside and serve as potential satellites to support growth (ibn.fm/TOOii).

The Santa Fe Mine project has a notable pedigree. Between 1988 and 1995, prior open-pit, heap-leach operations produced an estimated 356,000 ounces of gold and 784,000 ounces of silver. Today, Lahontan reports a National Instrument 43-101 compliant Indicated Mineral Resource of roughly 1,539,000 ounces gold equivalent at 0.99 g/t, and an Inferred resource of 411,000 ounces gold equivalent at 0.76 g/t, constrained to a pit shell. As it stands, Santa Fe is slated for further drilling at York and Slab, metallurgical refinement, and continuing permitting efforts.

In June, Lahontan received approval from the U.S. Bureau of Land Management for additional drill sites on federal lands at Santa Fe, expanding the company’s ability to test extensions into the Slab and York areas (ibn.fm/OhC5T). That approval opens the door to testing significant resource growth potential beyond known limits. The company intends to commence drilling shortly under its 2025 program as part of phase 1 work.

Meanwhile, at West Santa Fe the company sees upside potential as a satellite to the main Santa Fe project. Historical sampling and mapping indicate high gold and silver grades, rock chips reaching up to 2.61 g/t Au and as much as 899 g/t Ag, leading Lahontan to propose initial drilling of approximately 3,000 meters to define a formal mineral resource estimate (ibn.fm/Uxp4v). The exploration target there is conceptual, but the style and structural setting are similar to Santa Fe, offering potential leverage to the core asset.  

Lahontan’s approach is to balance near-term development with exploration upside. The company views Santa Fe as its production anchor and is working to derisk the project via permitting, metallurgical refinements and resource expansion. At the same time, the satellite assets give optionality and growth potential should additional discoveries be made. The management team strives for capital efficiency and advancing milestones while keeping exploration optionality alive.  

Investors drawn to gold in 2025 will notice that juniors such as Lahontan offer a leveraged way to ride the metal’s upside. Unlike major producers, juniors have the potential to deliver outsized returns if exploration and development go well. Lahontan’s presence in Walker Lane is an advantage: Nevada is a premier U.S. mining jurisdiction with supportive regulation, infrastructure, workforce and mining culture, reducing some of the geological and permitting unpredictability seen elsewhere.

As Lahontan advances Santa Fe and its satellite properties, the company seeks to convert resource ounces into economic viability. The next major catalysts include results from the 2025 drilling program, updates to the Preliminary Economic Assessment (“PEA”) and permitting progress. If those steps validate the project’s scale and cost structure, Lahontan could emerge as a new gold developer in a district known for delivering value.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology

This article has been disseminated on behalf of Ucore Rare Metals and may include a paid advertisement.

  • China’s actions have dramatically escalated since April 2025, when it announced export restrictions.
  • Once raw rare earth ores are mined, the most technically complex, costly and regulatory-sensitive steps are separation, refining and magnet manufacturing.
  • Ucore Rare Metals is stepping in to help alleviate the bottleneck.

When supply chains are weaponized, entire industries hang in the balance. China’s 2025 export licensing and control measures over rare-earth alloys, mixtures and magnets have become a real bottleneck for manufacturers and defense companies that rely on those materials. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is stepping into that gap, advancing its RapidSX(TM) processing technology and a U.S.-aligned rare-earth strategy aimed at reducing dependence on China and ensuring early production by next year.

China’s actions have dramatically escalated since April 2025, when it announced export restrictions on seven medium and heavy rare-earth elements, including samarium, gadolinium, terbium, dysprosium, lutetium, scandium and yttrium, along with related permanent magnets and mixtures. These export controls cover all destination countries, not just the United States, meaning that companies which are normally secure in their supply chains, including many in the defense sector, suddenly face delays or uncertainty in accessing essential materials. 

Automakers, electronics companies, aerospace firms and manufacturers of components for defense systems have sounded alarms. Reuters reported that Germany’s automakers are warning that China’s restrictions could force production halts without rapid licensing or alternative sourcing (https://ibn.fm/HtDhL).

Even more striking is how specialized some of the blocked materials are: rare‐earth magnets and components that are critical for permanent magnet motors used in electric vehicles, drones, weapon systems, guidance systems and sensors. In mid-June 2025, the Chinese government began issuing a small number of export licenses for some magnets and alloys, but the backlog of unprocessed applications remains large (https://ibn.fm/nNpXT).

The partial licensing has offered temporary relief for U.S. automakers and European manufacturers, but many warn the instability remains. The trade truce talks between the United States and China left some military‐use magnets unlicensed, a point of tension and concern for companies that build both consumer goods and defense hardware. 

The control over exports acts as a bottleneck because once raw rare-earth ores are mined, the most technically complex, costly and regulatory-sensitive steps are separation, refining and magnet manufacturing. China still dominates those mid- and downstream steps globally. Even if raw supply is available elsewhere, without licensed, high-quality separation and refining capacity in the U.S. or allied nations, companies remain vulnerable. 

In some cases, U.S. defense or aerospace contractors have reported that they cannot obtain particular specialty magnet grades necessary for systems unless they are approved via these constrained licensing channels. This uncertainty affects procurement and scheduling, and in many cases it has pushed firms to look for stockpiles or alternative suppliers, which can be more expensive or less reliable.

Ucore Rare Metals is stepping in to help alleviate the problem (https://ibn.fm/rou3P). The company has gained notable momentum with U.S. government support. In May 2025, Ucore secured a $18.4 million funding agreement with the U.S. Department of Defense to advance its RapidSX separation technology toward full-scale production in its Strategic Metals Complex in Alexandria, Louisiana (https://ibn.fm/E2ITq). The funding covers construction of a production-ready RapidSX machine, infrastructure and tech transfer from its Canadian demonstration facility. The goal is to reach early production of rare-earth oxide products in the second half of 2026.

RapidSX is Ucore’s proprietary processing technology platform designed to separate and purify both heavy and light rare-earth elements more efficiently, with modular scalable units and a smaller environmental footprint than many conventional solvent extraction methods (https://ibn.fm/10I3E). Ucore’s Commercial Demonstration Facility in Kingston, Ontario, has already been operating with its demo plant largely continuously processing mixed feedstocks and testing flow sheets to validate the RapidSX system’s performance. These demonstration runs help de-risk the scale-up to the Louisiana Strategic Metals Complex (“SMC”).

On top of technology, Ucore is addressing regulatory and financial levers. The project in Louisiana has received tax incentives from the state, including an Industrial Tax Exemption Program estimated to save about $8.2 million over a 10-year period for the facility, and longstanding lease arrangements, land acquisition and site preparation work. Feedstock partnerships are being developed, bolstering non-China-sourced materials.

All of this positions Ucore to potentially produce rare-earth oxide (“REO”) or total rare-earth oxide (“TREO”) outputs first in modest volumes, ramping up toward thousands of tonnes annually as its SMC comes online. The licensing bottleneck that China’s restrictions have imposed has highlighted the strategic urgency for companies such as Ucore. If Ucore meets its 2026 milestone, it could become a key Western source of REEs and magnets, reducing the vulnerability of U.S. manufacturers and defense contractors to external supply risks.

For more information, visit www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’

  • Forward Industries is the largest publicly traded Solana treasury platform with more than 6.8 million SOL acquired to date.
  • The company raised $1.65 billion in a PIPE led by Multicoin Capital, Galaxy Digital, and Jump Crypto to fund its Solana treasury acquisition.
  • Forward generates yield through active staking, lending, and DeFi participation, increasing SOL-per-share over time.
  • The company tokenized its common stock on the Solana blockchain and plans to acquire an equity stake in Superstate to expand on-chain capital markets access.
  • Forward is led by crypto-native investors with deep strategic alignment in the Solana ecosystem.

Forward Industries (NASDAQ: FORD) is building and managing a large-scale Solana (“SOL”) treasury, backed by some of the most influential investors in the digital asset space. The company’s strategy centers on long-term shareholder value through active participation in the Solana ecosystem, which it views as uniquely positioned to underpin future global capital markets due to its high throughput, deep economic activity, and growing developer adoption.

Through this shift, Forward Industries aims to create value by accumulating SOL and strategically deploying assets through on-chain opportunities including staking, lending, and participation in decentralized finance (“DeFi”). Forward also became the first U.S.-listed company to bring its common stock onto the Solana blockchain, reinforcing its focus on digital-native capital markets.

Forward Industries is headquartered in New York.

Solana Treasury Operations

In September 2025, Forward Industries closed a $1.65 billion private investment in public equity (“PIPE”) led by Multicoin Capital, Galaxy Digital, and Jump Crypto. The PIPE proceeds were deployed to acquire over 6.8 million SOL at an average price of $232 per token, with a portion executed on-chain via DFlow, a decentralized exchange aggregator built exclusively for Solana trading applications. The company has since staked the entirety of its treasury, actively generating yield through native Solana infrastructure and DeFi applications.

Forward’s strategy is centered on growing SOL per share, leveraging a range of tools including at-the-market (“ATM”) equity offerings and potential preferred equity issuance. The company is also targeting acquisitions and strategic partnerships within the Solana ecosystem to accelerate treasury yield and ecosystem alignment. As part of its infrastructure expansion, Forward tokenized its FORD shares on the Solana blockchain in collaboration with Superstate and plans to acquire an equity interest in the platform. The tokenized shares are expected to enable 24/7 trading, real-time settlement, and eligibility for use as DeFi collateral.

This shift was supported by the company’s board and executive team, whose composition reflects deep alignment with the Solana ecosystem — including leadership from Multicoin Capital and board observers from Galaxy and Jump Crypto. The company’s stated objective is to establish itself as the leading institutional participant in the Solana ecosystem, uniquely positioned to capture both economic yield and strategic exposure to one of the fastest-growing blockchain networks in the world.

Market Opportunity

Solana has emerged as the most performant blockchain in the digital asset space, processing over 8.9 billion transactions in Q2 2025 and sustaining approximately $3 billion in daily decentralized exchange (“DEX”) trading volume. Year to date, Solana applications have generated over $4 billion in fees and more than $1 billion in real economic value (“REV”), a proxy for free cash flow generated by the network.

DeFi participation, stablecoin usage, and developer activity have all grown substantially, with over $1.5 trillion in swap volume recorded through 2025. SOL staking yields have averaged over 8%, comprised of both inflationary rewards and organic yield from network activity. With 17 pending ETF applications and major institutions like BlackRock, Visa, PayPal, and HSBC integrating Solana, Forward Industries is positioned to benefit from a rising tide of institutional adoption, tokenization of real-world assets, and increased demand for high-performance blockchain infrastructure.

Leadership Team

Kyle Samani, Chairman of Forward Industries, is the co-founder and Managing Partner of Multicoin Capital, an early Solana backer and one of the largest holders of SOL. Samani contributed $25 million to the PIPE and is a key strategic leader behind Forward’s treasury roadmap.

Mike Pruitt, Interim CEO of Forward Industries, joined the board in February 2025 and was appointed Interim CEO in May. He is the founder of Avenel Financial Group and previously served as CEO of Chanticleer Holdings, bringing decades of public company leadership and capital markets experience.

Kathleen Weisberg, Chief Financial Officer of Forward Industries, was appointed CFO in July 2023 after serving as Corporate Controller since 2020. Weisberg is a CPA with prior roles at WW International, Symbol Technologies, and Ernst & Young.

For more information, visit the company’s website at https://sol.forwardindustries.com.

NOTE TO INVESTORS: The latest news and updates relating to FORD are available in the company’s newsroom at https://ibn.fm/FORD

Invaluable Insights Offered at the Social Media Strategies Summit Higher Education Conference 2025

Executives, leaders, and social media marketing heads from leading colleges and universities will gather at the Social Media Strategies Summit for Higher Education 2025. Tickets include access to the Higher Ed Summit on October 20–21 and access to the Corporate Brand Summit on October 23–24. The workshops are optional and can be accessed through separate registration. Attractive early bird offers are available.

Experts will conduct sessions on October 20-21, 2025, where they explore and share insights on the best social media marketing practices for colleges and universities. Eminent professionals from the higher education social media marketing realm all across the country will attend the conference to share important knowledge on the newest and best social media marketing strategies.

The event is a mammoth learning platform for executives and professionals in recruitment, admissions, social media marketing, and student experiences, where they can connect with peers and industry leaders to share and learn the best practices.

The two-day conference will feature speaker sessions, panel discussions, a live chat stream, and a Q&A session, where attendees can have their queries addressed by experts. Three of the speakers will also host the ‘Ask Me Anything’ session, where they will explore relevant topics to offer unique insights and perspectives.

Experts will also navigate important topics, such as the role of AI in social media, translating data into strategic insights, building a thriving community on social media, amplifying student voices while maintaining a positive reputation, and more.

For the last 11 years, the SMSsummit has successfully offered the latest research, tools, and strategies that add value to the existing skill set of social media marketing for universities and colleges.

To learn more, please visit https://ibn.fm/aKv4A.

DGE Hosts the 5th Investigator-Initiated Trials Summit in Philadelphia 

The 5th Investigator-Initiated Trials Summit will take place in Philadelphia on November 13–14, 2025

As the premier gathering for life sciences professionals driving IIT programs, this event unites clinical leaders, researchers, and industry experts to dissect common challenges happening in the IIT space. 

Investigator-initiated research continues to serve as a cornerstone of clinical innovation, creating opportunities to explore new indications, expand therapeutic options, and improve patient outcomes.

Hosted by Dynamic Global Events, the 5th IIT Summit features a distinguished speaking faculty offering proven strategies to streamline study activation, meet your study milestones, go over bottlenecks in clinical contracting, and much more!

Whether you join us in person in Philadelphia or virtually via our interactive platform, the IIT Summit provides the insights and connections you need.

Topics Covered Will Include:

  • Meet Your Milestones for Smoother Trial Execution
  • Leverage Dashboards to Drive Accelerated Trial Activation
  • Analyze Contracting Challenges and Negotiation Techniques
  • Fill Gaps in Clinical Practice and Advance Unanswered Medical Questions
  • Build a connected ecosystem to accelerate scientific breakthroughs and discoveries in Academic Medical Centers
  • Examine The Challenges that Accompany Collaborative Research

Register today to secure your spot for this year’s Investigator Initiated Trials Conference! 

To learn more, please visit https://ibn.fm/8QVuN.

GlobalTech Corp. (GLTK) Weaves a Portfolio of AI-Powered Solutions That Are Revolutionizing Industries Like Sports, E-commerce, Education and Others

  • GlobalTech Corp. Is a tech holding company that specializes in AI, big data, digital infrastructure, the cornerstone of the company’s growth
  • It has a portfolio of AI-powered products and companies in numerous industries, such as education, sports, E-commerce, hiring, and others
  • The company recently announced closing of a $1.4 million convertible note private placement, with the proceeds being used to support strategic priorities

GlobalTech (OTC: GLTK) is a technology holding company that specializes in industries like AI, big data, and digital infrastructure. The company continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances.

GLTK has a strong portfolio of products and acquisitions in a variety of industries like digital lending, compliance, retail, sports, recruitment, and eLearning/training. This includes solutions like Cadnz, ThrivoAI, Baseball Blitz and others.

Cadnz is a lending-lifecycle management platform aimed primarily at US banks and credit unions. The platform’s tools are focused on streamlining workflows, improving risk monitoring, and making decision-making faster and more accurate. Cadnz positions itself as a “smart, integrated solution” to reduce friction in lending and to help financial institutions handle origination, risk, and compliance more efficiently.

ThrivoAI is a business amplification platform that unifies business intelligence from every touch point into one ecosystem. The platform aims to help you boost conversions, improve consistency, and increase performance. It connects all stages of your value chain and improves decision-making and customer understanding by organizing data and turning it into actionable insights.

Baseball Blitz is a digital hub for all things baseball, and offers everything from league management to player development, fan engagement, and scouting. It lets you schedule games, track stats, manage teams, provide real-time updates, show off player profiles and highlights, and more.

In addition to their vast enterprise solutions, GlobalTech Corp. has also recently announced it has closed a convertible note private placement funding of $1.4 million. The notes are automatically convertible to common stock (at a 15% discount) upon a future IPO for GlobalTech Corp.

The proceeds from this investment are being used to fund and support various strategic priorities, including developing AI-powered solutions, expanding into high-growth international markets, and potentially making more acquisitions.

About GlobalTech Corp. (GLTK)

GlobalTech Corp. is a technology holding company with a focus on AI, big data and digital infrastructure. The company’s enterprise spans many AI solutions across industries and helps unlock the full potential of these organizations and platforms by offering access to capital markets and cutting-edge technologies.

For more information, visit www.GlobalTechCorporation.com.

NOTE TO INVESTORS: The latest news and updates relating to GLTK are available in the company’s newsroom at ibn.fm/GLTK

Oncotelic Therapeutics Inc. (OTLC) Venture Sapu Nano Receives Approval to Begin Human Clinical Trials of Sapu003, an Injectible Form of Afinitor(R) (Everolimus) for Breast Cancer Treatment

  • Sapu Nano received approval from Australia’s Human Research Ethics Committee (“HREC”) to start enrolling patients in clinical trials for Sapu003
  • Sapu003 uses Sapu Nano’s Deciparticle(TM) technology to deliver more of the Everolimus drug into the bloodstream, which could be more effective than taking the drug in pill form
  • Sapu Nano is a part of a family of companies formed through GMP Biotechnology Limited, which itself is a joint venture between Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Dragon Overseas Capital Limited

Sapu Nano, part of a group of companies formed through GMP Biotechnology Limited, which is a joint venture between Oncotelic Therapeutics (OTCQB: OTLC) and Dragon Overseas Capital Limited, recently received approval from the HREC in Australia to begin enrolling people in clinical trails of Sapu003 for the treatment of breast cancer.

Sapu003 is an injectible from of Affinitor(R) (Everolimus), which is an FDA-approved drug for treating different types of advanced cancer including breast cancer, kidney cancer, and affiliated rare tumors.

When taken orally in pill form, only about 10% of the drug is absorbed by the body, limiting how effective it can be. With that in mind, using Sapu Nano’s novel Deciparticle(TM) technology, Sapu003 that’s injected intravenously opens 100% of the drug reach the bloodstream.

As a result, Sapu003 represents a new approach to administering an existing cancer drug. Delivering the drug intravenously lets researchers give it at full strength, which may make it more effective at reducing the size of tumors.

This first trial aims to see if this improved version of the drug gives breast cancer patients not only new hope, but also more long-term and enduring benefits.

Dr. Vuong Trieu, the CEO of Sapu Nano, stated, “We are extremely pleased to receive approval from HREC to proceed with human clinical trials,”. He also added that “Despite advances in treatment, a critical unmet need for next generation mTOR inhibitors remains. Current therapies often extend progression-free survival for less than one year and rarely deliver long-term disease control. This Phase 1 trial will allow us to determine the best dose for future studies, including a Phase 3 trial. (ibn.fm/dY3G0)”

Dr. Sud Agarwal, CEO of Ingenu, a contract research organization (“CRO”) in Australia, added that “the approval of Sapu003 to enter human trials is a landmark moment. By enabling full drug absorption through intravenous delivery, this program has the potential to achieve meaningful tumor shrinkage where oral formulations have been limited. We are proud to support Sapu Nano in advancing this therapy, potentially giving breast cancer patients better outcomes and improved quality of life.”

About Oncotelic Therapeutics, Inc. 

Oncotelic Therapeutics is a biopharmaceutical company that develops therapeutics for cancer and other underserved diseases. The company has a portfolio of clinical-stage candidates and is focused on transforming outcomes for patients suffering from rare and/or difficult-to-treat conditions.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

From Our Blog

Beeline Holdings, Inc. (NASDAQ: BLNE), On Track To Go Cash Flow Positive

November 4, 2025

Beeline Holdings (NASDAQ: BLNE), a technology-forward mortgage and title platform that leverages AI, automation, and intuitive user experiences to simplify home financing, hit a significant milestone on September 5, 2025, having paid off all its debts, staying on track to go cash flow positive by Q1, 2026. While appearing on the latest episode of The […]

Rotate your device 90° to view site.